On the afternoon of January 17, a delegation of nine people, including Chen Shifei, Deputy Director of Zhejiang Provincial Food and Drug Administration, Qi Yongyuan, Vice Mayor of Lishui City, and Xia Haiguo, Director of Lishui Municipal Market Supervision Bureau, conducted an inspection visit to our company.

After watching the company's promotional video and listening to the reports by Chairman Wu Lihua and other senior executives on the R&D of traditional Chinese medicine formula granules, the construction of Chinese medicinal material planting bases, the operation of pharmaceutical commerce, and the building of corporate culture, Deputy Director Chen Shifei and his entourage affirmed and praised the company's operation management and development strategy. Deputy Director Chen stated that there were three unexpected aspects: first, the company's R&D of traditional Chinese medicine formula granules is quite mature and has remained unwavering for so many years; second, the company has a sound industrial layout, business strategy, and cultural construction; third, the company's management team is young and full of vitality. He also mentioned that investment in drug R&D requires great patience, and it is indeed not easy to persist in it with unwavering dedication for many years. He expressed that if the company encounters difficulties, especially those related to policies, the Provincial Food and Drug Administration will do its best to provide assistance or solve problems within its capacity. Vice Mayor Qi also noted that the modernized production of traditional Chinese medicine is in line with the industrial development direction of Lishui. Seeking benefits from ecology, promoting agricultural transformation, increasing farmers' income, and developing traditional Chinese medicine production and Chinese medicinal material planting are indeed a good path. Director Xia Haiguo of the Municipal Market Supervision Bureau, who accompanied the inspection, and others also shared their views respectively.